[Myotomy-myomectomy as treatment of localized hypertrophic cardiomyopathy].
We report the surgical treatment of 23 patients with local hypertrophic cardiomyopathy (LHM). Fifteen patients, group I (65.3%), with LHM were treated by myotomy-myectomy alone. Eight patients, group II (34.7%), with LHM and other cardiac disease, was treated by myotomy-myectomy and complementary procedure (mitral or aortic replacement, correction of congenital malformation). This group II had the major morbidity and mortality. Five years follow up had a 76.14% survival.
Santibáñez Escobar
F
F
Instituto Nacional de Cardiología Ignacio Chávez, México D.F.
Serrano Gallardo
G
G
Ramírez Marroquín
S
S
Zúñiga Monge
J C
JC
Herrera Alarcón
V
V
Venegas Hermosillo
F
F
Cisneros Tamayo
E
E
Barragán García
R
R
D000293:Adolescent; D000328:Adult; D001021:Aortic Valve; D002312:Cardiomyopathy, Hypertrophic / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006346:Heart Septum / Q000601:surgery*; D006350:Heart Valve Prosthesis; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve; D013997:Time Factors
Miotomía-miectomía como tratamiento de la miocardiopatía hipertrófica localizada.